Bill Humphries joined Valeant Pharmaceuticals on January 2, 2017, as Executive Vice President, Company Group Chairman for Dermatology and OraPharma. Previously, he was appointed CEO of Merz North America in March 2012, where he served until December 2016. Prior to joining Merz, Mr. Humphries served as the President of Stiefel, a leader in global dermatology and skin health, where he spearheaded two major acquisitions, and led the global integration of Stiefel into GlaxoSmithKline. Mr. Humphries held multiple senior executive roles within Allergan, Inc., concluding as Vice President of the U.S. Skincare business. Mr. Humphries has more than 29 years of experience in the specialty pharmaceutical industry, with more than 26 of those years focused on the commercialization of dermatology specialty pharmaceutical products. He currently is the Chair of the North Carolina State University Global Luxury Management Board and serves on the Board of Clearside Biomedical, the Women’s Dermatologic Society Industry Advisory Board, the steering committee for Carolina Entrepreneurial Development, and the Aclaris Therapeutics Board.

My 1:1 Connection is: My father, who is a retired pharmaceutical executive and Ortho Dermatologics alumni. Ever since I entered the world of pharmaceuticals, and specifically dermatology, he’s been a tremendous mentor and patient teacher.

Ed has a robust background in pharmaceuticals, including more than fifteen years in dermatology focused on medical and aesthetic marketing. Ed came to Valeant from the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc., where he was the Global Group Product Director overseeing marketing for a dermatology portfolio that increased net sales every year. Ed was also responsible for commercial business development, the company pipeline, alternate-selling channels and co-promotion agreements, including promotion of Stelara in psoriasis and Ertaczo in podiatry. Ed has been recognized at Valeant with the 2015 Chairman’s Award for Excellence and a 2016 Executive Vice President Leadership Award.

My 1:1 Connection is: Dermatology has been my professional focus for a long time but the personal relationships I have in the dermatology community are the most gratifying part of my experience.

Mr. Hahn joined Valeant in 2011 as Director, Professional Relations for Valeant Dermatology. Previously, Mr. Hahn worked at the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc., for more than 20 years, holding positions of responsibility, including Director of Professional Relations, where he oversaw key opinion leader programs for both general and aesthetic dermatology. During Mr. Hahn's tenure at Ortho Dermatologics, he won the Sales Leader Club Award three times. More recently, he won the Executive Vice President Leadership Award. Mr. Hahn has more than 27 years of experience in the specialty pharmaceutical industry.

My 1:1 Connection is: I spent over 20 years working at Ortho Dermatologics; so being part of this new exciting Ortho Dermatologics story is like coming home for me.